Clifton E. Barry, III, PhD

National Institute of Allergy and Infectious Diseases

Clifton E. Barry III received his PhD in organic and bioorganic chemistry in 1989 from Cornell University, studying the biosynthesis of complex natural products. Following postdoctoral research at Johns Hopkins University, he joined the National Institute of Allergy and Infectious Diseases Rocky Mountain Laboratories. In 1998 he was tenured as Chief of the Tuberculosis Research Section (TBRS) and relocated his laboratory to the National Institutes of Health main campus in Maryland. He is Principle Investigator on several overseas clinical trials studying tuberculosis and anti-tuberculosis chemotherapy in Korea, China and Nigeria. Dr. Barry is a member of several editorial boards and has authored more than 120 research publications in tuberculosis since entering the field 16 years ago. In 2009 he was named by ScienceWatch as the most highly cited researcher working in the field of tuberculosis.